Am. Colapietro et al., CHARACTERIZATION OF BENZO[A]PYRENE-INITIATED MOUSE SKIN PAPILLOMAS FOR HA-RAS MUTATIONS AND PROTEIN-KINASE-C LEVELS, Carcinogenesis, 14(11), 1993, pp. 2289-2295
The frequency and spectrum of Ha-ras mutations in benzo[a]pyrene ]P)-i
nitiated/12-O-tetradecanoylphorbol-13-acetate (TPA)-promoted CD-1 mous
e skin papillomas were characterized by amplifying high molecular weig
ht papilloma DNA using the polymerase chain reaction (PCR) followed by
direct DNA sequencing. Analysis of 10 individual B[a]P-initiated earl
y emergence papillomas indicated that 90% contained a Ha-ras mutation.
Twenty percent of these papillomas contained a GGA --> GTA transversi
on in the 12th codon, 50% contained a GGC --> GTC transversion in the
13th codon and 20% contained a CAA --> CTA transversion in the 61st co
don. A characteristic of 7,12-dimethylbenz[a]anthracene (DMBA)-initiat
ed papillomas, which contain an A-T mutation in the 61st codon of Ha-r
as, is that they exhibit a constitutive decrease in both protein kinas
e C (PKC) activity and PKCalpha and beta2 isozyme levels when compared
to epidermis. In the present study we found that total PKC activity,
as well as PKC alpha and beta2 isoforms, were markedly decreased in B[
a]P-initiated early emergence papillomas and that this decrease was al
so accompanied by an altered subcellular distribution of PKC activity.
The particulate/cytosolic (P/C) ratio of PKC activity in the epidermi
s was 0.39, whereas the P/C ratio in the papillomas was 0.77. These re
sults demonstrate that B[a]P-initiated/TPA-promoted papillomas exhibit
a high incidence of specific ras mutations and that PKC levels are co
nstitutively decreased in these papillomas, indicating that an activat
ed ras gene is associated with and may contribute to the observed decr
ease in PKC levels.